THARIMMUNE INC (THAR) Forecast, Price Target & Analyst Ratings

NASDAQ:THARUS4327053090

Current stock price

4.74 USD
+0.26 (+5.8%)
At close:
4.8255 USD
+0.09 (+1.8%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for THARIMMUNE INC (THAR).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 7.59% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 25, 2026

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 7.59%
From current price of $4.74 to mean target of $5.10, Based on 7 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for THAR. The average price target is 5.1 USD. This implies a price increase of 7.59% is expected in the next year compared to the current price of 4.74.

Analyst Ratings & History

Current Analyst Ratings

THAR Current Analyst RatingTHAR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

THAR Historical Analyst RatingsTHAR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
THAR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about THAR.
In the previous month the buy percentage consensus was at a similar level.
THAR was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-12-06Rodman & RenshawInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 25, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
THAR revenue by date.THAR revenue by date.
N/AN/A
EBITDA
YoY % growth
THAR ebitda by date.THAR ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
THAR ebit by date.THAR ebit by date.
-1.424M-1.808M
-27.00%
-3.208M
-77.40%
-6.882M
-114.52%
-9.455M
-37.39%
-12.434M
-31.50%
N/A
-18.95%
N/A
65.87%
Operating Margin
THAR operating margin by date.THAR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
THAR eps by date.THAR eps by date.
N/AN/AN/AN/A-198.20
33.57%
N/A
96.17%
N/A
5.23%
N/A
99.01%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

THAR Yearly EPS VS EstimatesTHAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

THARIMMUNE INC / THAR Forecast FAQ

What do analysts expect the price target to be for THARIMMUNE INC (THAR)?

7 analysts have analysed THAR and the average price target is 5.1 USD. This implies a price increase of 7.59% is expected in the next year compared to the current price of 4.74.

When does THARIMMUNE INC (THAR) report earnings?

THARIMMUNE INC (THAR) will report earnings on 2026-03-25, before the market open.

What is the consensus rating for THARIMMUNE INC (THAR) stock?

The consensus rating for THARIMMUNE INC (THAR) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.